Aakaar Medical Seeks Shareholder Approval for Executive Appointment and Remuneration
Aakaar Medical Technologies Ltd · Others (Uncategorized) · 04 Nov 2026, 7:01 pm
Aakaar Medical Seeks Shareholder Approval for Executive Appointment and Remuneration Aakaar Medical Technologies issued a postal ballot notice seeking shareholder approval via remote e-voting from 5th Nov'26 to 4th Dec'26 for key leadership resolutions. The company proposed appointing Abhash Dilip Meswani as a Director, Whole-time Director, and Key Managerial Personnel for five years starting 1st Nov'26, alongside his role as Vice President – Xelix. The proposal includes an annual remuneration of ₹50 lakh (~0.75% of FY turnover), performance incentives up to 10% of net profit if EBITDA exceeds ₹15 crore, and related-party transaction approvals.
Original exchange filing (PDF)
More announcements from Aakaar Medical Technologies Ltd
- Aakaar Medical Technologies Limited has informed the Exchange about the Publication Of Notice Of Postal Ballot and Remote E-Voting · 05 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Transcript · 02 Nov 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Link of Recording · 31 Oct 2026
- Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 31 Oct 2026
- Aakaar Medical Technologies Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026. · 30 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Investor Presentation · 30 Oct 2026
- Aakaar Medical Technologies Limited has informed the Exchange about Schedule of meet · 30 Oct 2026
- AAKAAR MEDICAL TECHNOLOGIES LIMITED has informed the Exchange about Board Meeting to be held on 30-Oct-2026 to consider and approve the Half Yearly Unaudited Financial results of the Company for the period ended September 2026 and ESOP. · 30 Oct 2026
